Skip to main content
SpringerLink
Log in

The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Prostate cancer (PCa) is the most commonly diagnosed cancer in Australia, accounting for one quarter of all new cancer diagnoses for males. Androgen deprivation therapy (ADT) is the standard first-line therapy for metastatic PCa but is also used across much of the spectrum of disease. Unfortunately, debilitating adverse effects are a significant and largely unavoidable feature of ADT. A recent systematic review of adverse effects of ADT identified 19 sub-groups classified according to the Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. The potential for multiple simultaneous adverse effects, their associated management and the impact of adverse effects on cancer outcomes and quality of life are important considerations in the treatment and supportive care of men with PCa. Exercise is increasingly being recognized as an efficacious strategy in managing these adverse effects.

Methods

A rapid review was undertaken to examine the role of exercise in the management of the most commonly reported ADT adverse effects classified according to the CTCAE sub-groups. A systematic search was conducted in Medline, PsycINFO, Google Scholar and Google for the years 2010 to September 2019 to identify the benefits of exercise in managing the adverse effects of ADT for PCa.

Results

There is strong evidence for exercise as medicine in addressing several of the adverse effects of PCa such as loss of muscle mass and strength, fatigue and declining physical function. Moderate level evidence for PCa exists for exercise-induced improvements in depression and anxiety, bone loss, and sexual dysfunction. While evidence of the effectiveness of exercise is lacking for many adverse effects of ADT for PCa, evidence in the cancer population as a whole or other clinical populations is strong, and many clinical guidelines recommend exercise as a fundamental part of their clinical management. With the exception of gynaecomastia and breast pain, there is increasing evidence (PCa, cancer or other clinical populations) to suggest that exercise has the potential to reduce and even prevent many of the adverse effects of ADT, thus improving survivorship outcomes for men with PCa.

Conclusion

Exercise has the potential to reduce and even prevent many of the adverse effects of ADT, thus improving survivorship outcomes for men with PCa. The use of exercise for PCa management has the potential to translate into health and economic benefits in improved quality of life and fewer complications, resulting in savings to the health care system, enhanced productivity and reduced patient and carer burden. Exercise thus has the potential to improve quality of life for this population as well as generate significant cost savings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Australian Institute of Health and Welfare (AIHW) (2014) Cancer in Australia: an overview 2014. AIHW, Canberra

    Google Scholar 

  2. International Agency for Research on Cancer (IARC) (2019). Cancer today: prostate cancer 2018

  3. Gordon L, Tuffaha H, James R, Keller A, Lowe A, Scuffham P et al (2018) Estimating the healthcare costs of treating prostate cancer in Australia: a Markov modelling analysis. Urol Oncol 36

  4. National Comprehensive Cancer Network (NCCN) (2018) Clinical practice guidelines in oncology (NCCN guidelines) Prostate Cancer

  5. Edmunds K, Tuffaha H, Galvão D, Scuffham P, Newton R (2020) Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic review. Support Care Cancer 28:2079–2093. https://doi.org/10.1007/s00520-019-05255-5

    Article  PubMed  Google Scholar 

  6. National Institutes of Health and National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0

  7. Vina J, Sanchis-Gomar F, Martinez-Bello V, Gomez-Cabrera M (2012) Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 167:1–12

    Article  CAS  Google Scholar 

  8. Hayes S, Spence R, Galvão D, Newton R (2009) Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise. J Sci Med Sport 12(4):428–434

    Article  Google Scholar 

  9. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM et al (2010) American College of Sports Medicine roundtable on exercise: guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1407–1426

    Article  Google Scholar 

  10. Kenfield S, Stampfer M, Giovannucci E, Chan J (2011) Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 29:726–732

    Article  Google Scholar 

  11. Newton R, Galvão D (2013) Exercise medicine for prostate cancer. Eur Rev Ageing Phys Act 5:41–45. https://doi.org/10.1007/s11556-012-0114-4

    Article  Google Scholar 

  12. Hayes S, Newton R, Spence R, Galvão D (2019) The exercise and sports science Australia position statement: exercise medicine in cancer management. J Sci Med Sport 22(11):1175–1199

    Article  Google Scholar 

  13. Campbell K, Winters-Stone K, Wiskemann J, May A, Schwartz A, Courneya K et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390

    Article  Google Scholar 

  14. Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, Morgans AK, Penson DF (2015) Prostate cancer survivorship care guideline: American society of clinical oncology clinical practice guideline endorsement. J Clin Oncol 33(9):1078–1085. https://doi.org/10.1200/JCO.2014.60.2557

    Article  PubMed  Google Scholar 

  15. National Comprehensive Cancer Network (NCCN) (2019) National Clinical Guidelines in Oncology (NCCN Guidelines) Survivorship Version 1.2019

  16. National Institute for Health and Care Excellence (NICE) (2019). Prostate cancer: diagnosis and management. https://www.nice.org.uk/guidance/ng131

  17. Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence Working Group (2016). The Oxford 2011 Levels of Evidence. http://www.cebm.net/index.aspx?o=5653

  18. Grossmann M, Zajac JD (2011) Androgen deprivation therapy in men with prostate cancer: How should the side effects be monitored and treated? Clin Endocrinol (Oxf) 74(3):289–293. https://doi.org/10.1111/j.1365-2265.2010.03939.x

    Article  Google Scholar 

  19. Joseph JS, Lam V, Patel MI (2019) Preventing osteoporosis in men taking androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol 2(5):551–561. https://doi.org/10.1016/j.euo.2018.11.001

    Article  PubMed  Google Scholar 

  20. Taaffe DR, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Hayne D, Cormie P, Shum DHK, Newton RU (2018) Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition. BJU Int 123(2):261–269. https://doi.org/10.1111/bju.14505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Uth J, Hornstrup T, Schmidt JF, Christensen JF, Frandsen C, Christensen KB, Helge EW, Brasso K, Rørth M, Midtgaard J, Krustrup P (2014) Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy. Scand J Med Sci Sports 24(SUPPL.1):105–112

    Article  Google Scholar 

  22. Newton RU, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA et al (2018) Exercise mode specificity for preserving spine and hip bone mineral density in prostate cancer patients. Med Sci Sports Exerc 51(4):607–614. https://doi.org/10.1249/MSS.0000000000001831

    Article  CAS  Google Scholar 

  23. Newton RU, Jeffery E, Galvão DA, Peddle-McIntyre CJ, Spry N, Joseph D et al (2018) Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy. BJU Int 122(6):986–993. https://doi.org/10.1111/bju.14384

    Article  CAS  PubMed  Google Scholar 

  24. Baumann FT, Zopf EM, Bloch W (2012) Clinical exercise interventions in prostate cancer patients: a systematic review of randomized controlled trials. Support Care Cancer 20(2):221–233

    Article  Google Scholar 

  25. Gardner JR, Livingston PM, Fraser SF (2014) Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 32(4):335–346

    Article  Google Scholar 

  26. Hasenoehrl T, Keilani M, Sedghi Komanadj T, Mickel M, Margreiter M, Marhold M, Crevenna R (2015) The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review. Support Care Cancer 23(8):2479–2497. https://doi.org/10.1007/s00520-015-2782-x

    Article  CAS  PubMed  Google Scholar 

  27. Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, Albertsen PC, Tombal B, Payne HA, Rosario DJ (2016) Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol 69(4):693–703

    Article  Google Scholar 

  28. Keilani M, Hasenoehrl T, Baumann L, Ristl R, Schwarz M, Marhold M, Sedghi Komandj T, Crevenna R (2017) Effects of resistance exercise in prostate cancer patients: a meta-analysis. Support Care Cancer 25:2953–2968

    Article  CAS  Google Scholar 

  29. Yunfeng G, Weiyang H, Xueyang H, Yilong H, Xin G (2017) Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy. Medicine (United States) 96(27). https://doi.org/10.1097/MD.0000000000007368

  30. Crawford-Williams F, March S, Goodwin BC, Ralph N, Galvão DA, Newton RU et al (2018) Interventions for prostate cancer survivorship: a systematic review of reviews. Psychooncology. 27:1339–2348

    Article  Google Scholar 

  31. O’Neill RF, Haseen F, Murray LJ, O’Sullivan JM, Cantwell MM (2015) A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer. J Cancer Surviv 9(3):431–440. https://doi.org/10.1007/s11764-014-0417-8

    Article  PubMed  Google Scholar 

  32. Gilbert SE, Tew GA, Fairhurst C, Bourke L, Saxton JM, Winter EM, Rosario DJ (2016) Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer. Br J Cancer 114(4):401–408. https://doi.org/10.1038/bjc.2015.479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Galvão DA, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK et al (2018) Exercise preserves physical function in prostate cancer patients with bone metastases. Med Sci Sports Exerc 50(3):393–399. https://doi.org/10.1249/MSS.0000000000001454

    Article  PubMed  Google Scholar 

  34. Grossmann M, Zajac J (2011) Management of the side effects of androgen deprivation therapy. Endocrinol Metab Clin N Am 40(4):655–671. https://doi.org/10.1016/j.ecl.2011.05.004

    Article  CAS  Google Scholar 

  35. Grossmann M, Hamilton EJ, Gilfillan C, Bolton D, Joon DL, Zajac JD (2011) Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. Med J Aust 194(6):301–306

    Article  Google Scholar 

  36. Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy J, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 140:e596–e646. https://doi.org/10.1161/CIR.0000000000000678

    Article  PubMed  Google Scholar 

  37. Colberg S, Sigal R, Yardley J, Riddell M, Dunstan D, Dempsey P et al (2016) Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 39(11):2065–2079

    Article  Google Scholar 

  38. The Royal Australian College of General Practitioners & Diabetes Australia. General practice management of type 2 diabetes 2016–2018. 2016

  39. Collins L, Mohammed N, Ahmad T, Basaria S (2012) Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care. J Endocrinol Investig 35(3):332–339

    CAS  Google Scholar 

  40. Beaudry R, Liang Y, Boyton S, Tucker W, Brothers R, Daniel K et al (2018) Meta-analysis of exercise training on vascular endothelial function in cancer survivors. Integr Cancer Ther 17(2):192–199

    Article  Google Scholar 

  41. Ahmadi H, Daneshmund S (2013) Androgen deprivation therapy: evidence-based management of side effects. BJU Int 111:543–548

    Article  CAS  Google Scholar 

  42. Fagerlund A, Cormio L, Palangi L, Lewin R, Di Pompeo FS, Elander A et al (2015) Gynecomastia in patients with prostate cancer: a systematic review. PLoS ONE 10(8). https://doi.org/10.1371/journal.pone.0136094

  43. Hamilton K, Chambers SK, Legg M, Oliffe JL, Cormie P (2015) Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer. Support Care Cancer 23(1):133–142. https://doi.org/10.1007/s00520-014-2327-8

    Article  CAS  PubMed  Google Scholar 

  44. Cormie P, Newton R, Taaffe D, Saunders JD, Akhil Hamid M et al (2013) Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis 16:170–175. https://doi.org/10.1038/pcan.2012.52

    Article  CAS  PubMed  Google Scholar 

  45. Chambers S, Dunn J, Lazenby M, Clutton S, Newton R, Cormie P et al (2013) ProsCare: a psychological care model for men with prostate cancer. Prostate Cancer Foundation of Australia (PCFA) and Griffith University, Australia

    Google Scholar 

  46. Chipperfield K, Brooker J, Fletcher J, Burney S (2014) The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review. Health Psychol 33(11):1288–1297. https://doi.org/10.1037/hea0000006

    Article  PubMed  Google Scholar 

  47. Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, Rosario DJ, Skolarus TA, Penson DF (2015) Survivorship and improving quality of life in men with prostate cancer. Eur Urol 68(3):374–383. https://doi.org/10.1016/j.eururo.2015.04.023

    Article  PubMed  Google Scholar 

  48. Keogh JWL, MacLeod RD (2012) Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Sympt Manage 43(1):96–110. https://doi.org/10.1016/j.jpainsymman.2011.03.006

    Article  Google Scholar 

  49. Baguley BJ, Bolam KA, Wright ORL, Skinner TL (2017) The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer. Nutrients. 9. https://doi.org/10.3390/nu9091003

  50. Larkin D, Lopez V, Aromataris E (2014) Managing cancer-related fatigue in men with prostate cancer: a systematic review of non-pharmacological interventions. Int J Nurs Pract 20(5):549–560. https://doi.org/10.1111/ijn.12211

    Article  PubMed  Google Scholar 

  51. Moe E, Chadd J, McDonagh M, Valtonen M, Horner-Johnson W, Eden K et al (2017) Exercise interventions for prostate cancer survivors receiving hormone therapy: systematic review. Transl J Am Coll Sports Med 2(1):1-9. https://doi.org/10.1249/TJX.0000000000000025 

  52. Vashistha V, Singh B, Kaura S, Prokop L, Kaushik D (2016) The effects of exercise on fatigue, quality of life, and psychological function for men with prostate cancer: systematic review and meta-analyses. Eur Urol Focus 2:284–295

    Article  Google Scholar 

  53. Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Cormie P, Bolam KA, Galvão DA (2017) Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. Eur Urol 72(2):293–299. https://doi.org/10.1016/j.eururo.2017.02.019

    Article  PubMed  Google Scholar 

  54. Segal R (2014) Physical functioning for prostate health. Can Urol Assoc J 8(7–8 Supplement 5):S162–S163. https://doi.org/10.5489/cuaj.2315

    Article  PubMed  PubMed Central  Google Scholar 

  55. Sherrington C, Fairhall N, Wallbank G, Tiedemann A, Michaleff Z, Howard K et al (2019) Exercise for preventing falls in older people living in the community (Review). Cochrane Database Syst Rev:CD012424(1). https://doi.org/10.1002/14651858.CD012424.pub2

  56. Lin X, Zhang X, Guo J, Roberts C, McKenzie S, Wu W et al (2015) Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 4(7). https://doi.org/10.1161/JAHA.115.002014

  57. Pan B, Ge L, Xun YQ, Chen YJ, Gao CY, Han X, Zuo LQ, Shan HQ, Yang KH, Ding GW, Tian JH (2018) Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Int J Behav Nutr Phys Act 15(1):72. https://doi.org/10.1186/s12966-018-0703-3

    Article  PubMed  PubMed Central  Google Scholar 

  58. Schellenberg E, Dryden D, Vandermeer B, Ha C, Korownyk C (2013) Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159:543–551

    Article  Google Scholar 

  59. Zanuso S, Sacchetti M, Sundberg CJ, Orlando G, Benvenuti P, Balducci S (2017) Exercise in type 2 diabetes: genetic, metabolic and neuromuscular adaptations. a review of the evidence. Br J Sports Med 51(21):1533–1538. https://doi.org/10.1136/bjsports-2016-096724

    Article  PubMed  Google Scholar 

  60. Scott J, Nilsen T, Gupta D, Jones L (2018) Exercise therapy and cardiovascular toxicity in cancer. Circulation. 137:1176–1191

    Article  Google Scholar 

  61. Green DJ, Hopman MT, Padilla J, Laughlin MH, Thijssen DH (2017) Vascular adaptation to exercise in humans: role of hemodynamic stimuli. Physiol Rev 97(2):495–528

    Article  CAS  Google Scholar 

  62. Janssen V, De Gucht V, Dusseldorp E, Maes S (2013) Lifestyle modification programmes for patients with coronary heart diease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prevent Cardiol 20:620–640. https://doi.org/10.1177/2047487312462824

    Article  Google Scholar 

  63. Northey J, Cherbuin N, Pumpa K, Smee D, Rattray B (2018) Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis. Br J Sports Med 52(3):154–160

    Article  Google Scholar 

  64. Blondell S, Hammersley-Mather R, Veerman J (2014) Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 14:510. https//doi.org/10.1186/1471-2458-14-510

  65. Meschia J, Bushnell CB, Boden-Albala B, Braun L, Dawn M. Bravata D, Chaturvedi S et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–3832

  66. Tsivgoulis G, Safouris A, Kim D-E, Alexandrovb A (2018) Recent advances in primary and secondary prevention of artherosclerotic stroke. J Stroke 20(2):145–166

    Article  Google Scholar 

  67. Carlson D, Dieberg G, Hess N, Millar P, Smart N (2014) Isometric exercise training for blood pressure management: a systematic review and meta-analysis. Mayo Clin Proc 89(3):327–324

    Article  Google Scholar 

  68. Carpio-Rivera E, Moncada-Jiménez J, Salazar-Rojas W, Solera-Herrera A (2016) Acute effects of exercise on blood pressure: a meta-analytic investigation. Arq Bras Cardiol 106(5):422–433. https://doi.org/10.5935/abc.20160064

    Article  PubMed  PubMed Central  Google Scholar 

  69. Cornelissen V, Smart N (2013) Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc 2(1):e004473

    Article  Google Scholar 

  70. Nelson MR, Doust JA (2013) Primary prevention of cardiovascular disease: new guidelines, technologies and therapies. Med J Aust 198(11):606–610. https://doi.org/10.5694/mja12.11054

    Article  PubMed  Google Scholar 

  71. National Vascular Disease Prevention Alliance (NVDPA) (2012) Guidelines for the management of absolute cardiovascular disease risk. NVDPA:1-124

  72. Brook R, Appel L, Rubenfire M, Ogedegbe G, Bisognano J, Elliott W, Fuchs FD, Hughes JW, Lackland DT, Staffileno BA, Townsend RR, Rajagopalan S, American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity (2013) Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension. 61:1360–1383

    Article  CAS  Google Scholar 

  73. Key N, Khorana A, Kuderer N, Bohlke K, Lee A, Arcelus J et al (2019) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 38(5):496–520

    Article  Google Scholar 

  74. Kahn SR, Shrier I, Kearon C (2008) Physical activity in patients with deep venous thromboembolism: a systematic review. Thromb Res 122:763–773

    Article  CAS  Google Scholar 

  75. Lambiase MJ, Thurston RC (2013) Physical activity and sleep among midlife women with vasomotor symptoms. Menopause (New York, NY) 20(9):946–952

    Article  Google Scholar 

  76. Moilanen J, Aalto AM, Hemminki E, Aro AR, Raitanen J, Luoto R (2010) Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas. 67:368–374

    Article  CAS  Google Scholar 

  77. van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H (2018) The effects of physical exercise on fatty liver disease. Gene Expr 18:89–101

    Article  Google Scholar 

  78. Golabi P, Locklear C, Austin P, Afdhal S, Byrns M, Gerber L et al (2016) Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review. World J Gastroenterol 22(27):6318–6327

    Article  Google Scholar 

  79. Whitsett M, van Wagner L (2015) Physical activity as a treatment of non-alcoholic fatty liver disease: a systematic review. World J Hepatol 7(16):2041–2052

    Article  Google Scholar 

  80. Schuch F, Vancampfort D, Richards J, Rosenbaum S, Ward P, Stubbs B (2016) Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res 77:42–51

    Article  Google Scholar 

  81. Craft L, Vaniterson E, Helenowski I, Rademaker A, Courneya K (2012) Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 21(1):3–19

    Article  Google Scholar 

  82. Brown A, Huedo-Medina T, Pescatello L, Ryan S, Pescatello S, Moker E et al (2012) The efficacy of exercise in reducing depressive symptoms among cancer survivors: a meta-analysis. PLoS One 7(1):e30955 https://doi.org/10.1371/journal.pone.0030955

  83. Mishra S, Scherer R, Geigle P, Berlanstein D, Topaloglu O, Gotay C et al (2012) Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Sys Rev. 8. https://doi.org/10.1002/14651858.CD007566.pub2

  84. Mishra S, Scherer R, Snyder C, Geigle P, Berlanstein D, Topaloglu O (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Sys Rev 8. https://doi.org/10.1002/14651858.CD008465.pub2

  85. Fong D, Ho J, Hui B, Lee A, Macfarlane D, Leung S et al (2012) Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ (Online) 344:e70. https://doi.org/10.1136/bmj.e70

    Article  Google Scholar 

  86. Winters-Stone KM, Dobek JC, Bennett JA, Maddalozzo GF, Ryan CW, Beer TM (2014) Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc 46(8):1482–1488. https://doi.org/10.1249/MSS.0000000000000265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Pernar CH, Ebot EM, Wilson KM, Mucci LA (2018) The epidemiology of prostate cancer. CSH Perspecti Med 8(12). https://doi.org/10.1101/cshperspect.a030361

  88. Greasely R, Turner R, Collins K, Brown J, Bourke L, Rosario D (2018) Treatment in the STAMPEDE for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems. BMC Cancer 18:667. https://doi.org/10.1186/s12885-018-4527-y

  89. Bourke L, Turner R, Greasley R, Sutton E, Steed L, Smith D et al (2018) A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS. PLoS ONE 13(7):e0197606-e. https://doi.org/10.1371/journal.pone.0197606

    Article  CAS  Google Scholar 

  90. Schmidt M, Østergren P, Cormie P, Ragle A, Sønksen J, Midtgaard J (2019) “Kicked out into the real world”: prostate cancer patients' experiences with transitioning from hospital-based supervised exercise to unsupervised exercise in the community. Support Care Cancer 27(1):199–208

    Article  Google Scholar 

Download references

Funding

Kim Edmunds’ PhD was supported by an Australian Post Graduate Awards (APA) scholarship and an Inspiring Minds scholarship from Edith Cowan University, Western Australia.

Author information

Authors and Affiliations

  1. Centre for Applied Health Economics, Griffith University, Brisbane, Australia

    Kim Edmunds & Paul Scuffham

  2. Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia

    Kim Edmunds & Paul Scuffham

  3. Centre for the Business and Economics of Health, University of Queensland, Brisbane, Australia

    Haitham Tuffaha

  4. Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Australia

    Daniel A Galvão & Robert U Newton

  5. School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia

    Robert U Newton

Authors
  1. Kim Edmunds
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haitham Tuffaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Scuffham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel A Galvão
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert U Newton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim Edmunds.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edmunds, K., Tuffaha, H., Scuffham, P. et al. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review. Support Care Cancer 28, 5661–5671 (2020). https://doi.org/10.1007/s00520-020-05637-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05637-0

Keywords

Search

Navigation